Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma

Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Adebrelimab and dalpiciclib Sponsors: Zhongzheng Xiang Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials